Risk Factors For Wound Dehiscence After Laparotomy - Clinical Control Trial
Risk Factors For Wound Dehiscence After Laparotomy - Clinical Control Trial
Risk Factors For Wound Dehiscence After Laparotomy - Clinical Control Trial
PRZEGLD CHIRURGICZNY
2012, 84, 11, 565573
10.2478/v10035-012-0094-0
566
J. Kenig et al.
Table 1. Indications and procedure scope in the group of patients with wound dehiscence
Indications (number)
colon cancer + rectal cancer
stomach cancer
neoplasm of the pancreaticoduodenal region
gastrointestinal tract perforation
gastrointestinal tract obstruction
cholecystitis/choledocholithiasis
acute pancreatitis
abdominal injury
acute appendicitis
intestinal inflammatory diseases:
Crohns disease
ulcerative colitis
foreign body in the gastrointestinal tract
hernia in the laparotomy scar
closure of loop ileostomy
morbid obesity
embolism of the inferior mesenteric artery
9+9
2
2
6
6
4
1
4
4
4
1
3
1
1
1
1
11
Surgery (number)
stomach
small intestine
large intestine
gallbladder/bile ducts
liver
pancreas
splenectomy
abdominal wall plastic surgery
exploratory laparotomy (lysis of adhesions)
6
7
28
5
2
1
1
2
4
567
Female
19
71,7+12,7
Male
37
64,312,4
P value
0,05
0,04
4 (21,1%)
15 (79%)
10 (52,6%)
7 (18,9%)
30 (81,1%)
15 (40,5%)
0,84
0,82
0,38
11 (58%)
10 (52%)
4 (36%)
2 (11%)
17 (89%)
8 (42,1%)
17 (45,9%)
14 (37,8%)
5 (13,5%)
8 (21,6%)
26 (70,3%)
18 (48,6%)
0,39
0,28
0,47
0,3
0,1
0,6
568
J. Kenig et al.
Factor
Tobacco smoking
Chronic steroid treatment
Procedures involving opening of the gastrointestinal tract
Surgery type:
stomach/duodenum
gall-bladder
small intestine
large intestine
other
Time to wound dehiscence
Vertical incision
Stay in the ICU
Biochemical tests:
WBC
HCT
HGB
CRP
albuminy / albumin
biaka / protein
kreatynina / creatinine
Death
Female
5 (26,3%)
1 (5,3%)
16 (84,2%)
Male
10 (27%)
6 (16,2%)
31 (83,8%)
P value
0,7
0,2
0,46
3 (15,8%)
1 (5,3%)
1 (5,3%)
11 (57,9%)
3 (15,8%)
9,45+6,9
18 (95%)
8 (42,1%)
2 (5,4%)
4 (10,8%)
8 (21,6%)
17 (46%)
6 (16,2%)
10,5+5,9
30 (81%)
18 (48,6%)
0,2
0,5
0,2
0,6
0,9
0,56
0,16
0,64
13,65,6
34,75,5
10,81,7
152,2130,9
254,2
49,47,9
96,328,5
126,2
36,68
12,85,4
111,392,5
33,313,4
53,615,6
100,852,7
0,3
0,4
0,15
0,3
0,05
0,5
0,4
6 (31,6%)
8 (21,6%)
0,41
Table 3. Comparison of the study group with the selected control group
Factor
Number of patients (M/F)
Age (years)
Surgery setting:
elective (11 patients)
emergency (45 patients)
Surgery type:
stomach/duodenum
gall-bladder
small intestine
large intestine
other
Wound dehiscence
Control group
P value
56 (37/19)
66,613
168 (95/73)
66,812,8
0,2
0,87
11 (20%)
45 (80%)
44 (26,2%)
124 (73,8%)
0,27
5 (9,1%)
5 (9,1%)
9 (16,4%)
27 (49,1%)
10 (16,4%)
14 (8,3%)
13 (7,7%)
36 (21,4%)
83 (49,4%)
22 (13,1%)
0,84
0,74
0,41
0,94
0,56
569
Czynnik / Factor
Procedures involving opening of the gastrointestinal tract
Neoplastic disease
Concomitant diseases:
hypertensive disease
coronary heart disease
diabetes
COPD
other
BMI:<20,5/20,5-30/>30 kg/m2 (n)
Previous surgery (n)
Tobacco smoking
Chronic steroid treatment
Surgical site infection
Anastomotic dehiscence/fistula
Circulatory failure (n)
Vertical incision (n)
Anti-eventration sutures (n)
Procedure time (n):
7-15.00
15.01-23.59
00.00-6.59
Stay in the ICU (n)
Length of hospital stay (days)
Biochemical tests:
WBC
HCT
HGB
CRP
albumin
protein
creatinine
Time to wound dehiscence (days)
Death
Grupa kontrolna /
Control group
P value
122 (72,6%)
71 (42,3%)
0,16
0,85
28 (50,9%)
23 (41,8%)
8 (14,5%)
9 (16,4%)
42 (76,4%)
12/31/13
25 (45,5%)
15 (27,3%)
7 (12,7%)
34 (61,8%)
5 (8,9%)
21 (37,5%)
47 (83,9%)
13 (23,2%)
92 (54,8%)
61 (36,3%)
28 (16,7%)
16 (9,5%)
116 (69%)
24/119/24
91 (54,2%)
41 (24,4%)
6 (3,6%)
23 (13,7%)
5 (3%)
43 (25,6%)
143 (85,1%)
27 (16,1%)
0,61
0,46
0,71
0,16
0,3
0,12
0,26
0,67
0,84
<0,01
1
0,04
0,95
0,2
24 (42,9%)
26 (46,4%)
6 (10,7%)
25 (45,5%)
38,327,1
81 (48,2%)
73 (43,5%)
14 (8,3%)
39 (23,2%)
15,812,9
0,68
0,73
0,89
0,001
<0,01
12,56,0
35,97,2
12,24,6
127,13108,2
30,212,9
52,4413,9
104,462,5
9,86,5
13 (23,2%)
11,65,9
37,76,4
12,42,2
111,49100,27
32,699,6
56,8513,8
91,9863,7
34 (20,2%)
0,3
0,1
0,7
0,5
0,3
0,2
0,3
0,6
Table 4. Analysis of risk factors in the study group using logistic regression
Factor
Oncological procedure
Procedure involving opening of the
gastrointestinal tract
Organ undergoing surgery
Coronary heart disease
Regression
coefficient
Odds
ratio
0,17
-0,03
1,2
1,3
0,13
0,23
0,9
1,1
2,1
1,8
P value
0,5
0,6
0,9
0,5
570
J. Kenig et al.
Czynnik / Factor
Hypertensive disease
Diabetes
Respiratory tract diseases
Previous surgery
Tobacco smoking
Chronic steroid treatment
Surgical site infection
Anastomotic dehiscence/fistula
Circulatory failure
Two-organ surgery
Vertical incision vs. other
Additional supporting sutures
Purulent material in the abdominal cavity
Damage to the gastrointestinal tract
Operating surgeon
Time of procedure:
month
time of day
Malnutrition (20.5)
Obesity (BMI 30)
Biochemical tests:
albumin
protein
leukocytes
CRP
hemoglobin
hematocrit
creatinine
Wspczynnik
regresji /
Regression
coefficient
-0,3
-0,4
0,2
0,7
0,3
0,7
1,3
0,1
0,09
0,1
0,1
-0,1
-0,6
0,7
0,13
Iloraz
szans
0,8
0,7
1,2
1,9
1,3
2,1
3,7
1,8
1,0
1
1,1
0,9
0,6
2,1
1,2
0,02
-0,1
0,2
0,2
1
0,9
1,2
1,2
0,9
0,5
0,6
0,7
1,1
1,4
2,3
2,4
0,7
0,6
0,4
0,5
0,03
-0,05
0,001
0,001
0,007
0,015
0,005
1,0
0,9
1
0,9
1
1
1
0,9
0,8
0,9
0,7
0,8
0,9
0,9
1,1
1,1
1,1
1,2
1,3
1,1
1,1
0,4
0,3
0,4
0,8
0,5
0,1
0,3
571
572
J. Kenig et al.
references
1. Jones V, Bale, S, Harding, K: Acute and chronic
wounds. Wound care essentials: Practice principles.
Philadelphia: Lippincott, Williams, & Wilkins
2004.
2. Szmidt J, Kuda J (red.): Podstawy chirurgii,
tom 1. Wydawnictwo Medycyna Praktyczna 2010.
3. Carlson MA: Acute wound failure. Surg Clin
North Am 1997; 77: 607-36.
4. Burger JW, Vant Riet M et al.: Abdominal incisions: techniques and postoperative complications.
Surg 2002; 91: 315-21.
5. Yahchouchy-Chouillard E, Aura T et al.: Incisional hernia related risk factors. Surg 2003; 20:
3-9.
6. Vant Riet M, Steyerberg EW, Nellensteyn J et
al.: Meta-analysis of techniques for closure of midline abdominal incisions. Br J Surg 2002; 89:
1350-56.
7. Ceydeli A, Rucinski J, Wise L: Finding the best
abdominal closure: an evidence-based review of the
literature. Curr Surg 2005; 62: 220-25.
8. Afzal S, Bahir mm: Determinants of Wound
Dehiscence in Abdominal Surgery in Public Sector
Hospital. Annals 2008; 14(3): 110-14.
9. Hodgson NC, Malthaner RA, Ostbye T: The search
for an ideal method of abdominal fascial closure: Ameta-analysis. Ann Surg 2000; 231: 436-45.
10. Richards PC, Balch CM, Aldrete JS: Abdominal wound closure. A randomized prostpective
study of 571 patients comparing continuous vs.
interrupted suture techniques. Ann Surg 1970;
238: 1983-89.
11. Van Ramshorst GH, Nieuwenhuizen J, Hop
WCJ: Abdominal Wound Dehiscence in Adults:
Development and Validation of aRisk Model. World
J Surg 2010; 34: 20-27.
12. Seleh M, Hill A, AG Hill: Smoking is amajor
risk factor of wound dehiscence after midline abdominal incision; case-control study. ANZ J Surg
2009; 79: 247-50.
13. Penninckx FM, Poelmans SV, Kerremans RP et
al.: Abdominal wound dehiscence in gastroenterological surgery. Ann Surg 1979; 189: 345-52.
14. Pavlidis TE, Galatianos IN, Papaziogas BT et
al.: Complete dehiscence of the abdominal wound
and incriminating factors. Eur J Surg 2001; 167:
351-54.
15. Humar A, Ramcharan T et al.: Are wound
complications after akidney transplant more common with modern immunosuppression? Transplantation 2001; 72: 1920-23.
16. Keill RH, Keitzer WF, Nichols WK et al.: Abdominal wound dehiscence. Arch Surg 1973; 106:
573-77.
573
Received: 29.10.2012r.
Adress correspondence: 31-202 Krakw, ul. Prdnicka 35/37